Allyson Cole-Strauss

2.1k total citations
32 papers, 1.5k citations indexed

About

Allyson Cole-Strauss is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Allyson Cole-Strauss has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 14 papers in Molecular Biology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Allyson Cole-Strauss's work include Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (8 papers) and Nerve injury and regeneration (5 papers). Allyson Cole-Strauss is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (8 papers) and Nerve injury and regeneration (5 papers). Allyson Cole-Strauss collaborates with scholars based in United States and Sweden. Allyson Cole-Strauss's co-authors include Eric B. Kmiec, Jack W. Lipton, Kyung Chul Yoon, Kyonggeun Yoon, Caryl E. Sortwell, William K. Holloman, Yufei Xiang, Bruce C. Byrne, Michael C. Rice and Kathy Steece‐Collier and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Allyson Cole-Strauss

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Allyson Cole-Strauss United States	20	920	346	319	280	151	32	1.5k
Pierre Lau United States	22	1.2k 1.4×	147 0.4×	310 1.0×	139 0.5×	294 1.9×	31	2.0k
Viviana Caputo Italy	23	863 0.9×	643 1.9×	439 1.4×	298 1.1×	230 1.5×	52	1.8k
Rebeca Mejı́as United States	16	508 0.6×	170 0.5×	197 0.6×	110 0.4×	280 1.9×	24	988
Stephan Züchner United States	23	854 0.9×	381 1.1×	853 2.7×	251 0.9×	129 0.9×	68	2.0k
Catherine B. Kunst United States	14	768 0.8×	290 0.8×	251 0.8×	627 2.2×	71 0.5×	14	1.3k
Atsushi Tsujimura Japan	21	536 0.6×	219 0.6×	378 1.2×	133 0.5×	206 1.4×	49	1.1k
Mark E. Hester United States	20	1.1k 1.2×	733 2.1×	390 1.2×	194 0.7×	241 1.6×	32	1.9k
Kohei Shimizu Japan	18	723 0.8×	203 0.6×	423 1.3×	198 0.7×	664 4.4×	32	1.9k
W. Michael Zawada United States	23	821 0.9×	369 1.1×	801 2.5×	114 0.4×	194 1.3×	35	1.8k
José I. Piruat Spain	19	649 0.7×	106 0.3×	307 1.0×	217 0.8×	123 0.8×	28	1.3k

Countries citing papers authored by Allyson Cole-Strauss

Since Specialization

Citations

This map shows the geographic impact of Allyson Cole-Strauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allyson Cole-Strauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allyson Cole-Strauss more than expected).

Fields of papers citing papers by Allyson Cole-Strauss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allyson Cole-Strauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allyson Cole-Strauss. The network helps show where Allyson Cole-Strauss may publish in the future.

Co-authorship network of co-authors of Allyson Cole-Strauss

This figure shows the co-authorship network connecting the top 25 collaborators of Allyson Cole-Strauss. A scholar is included among the top collaborators of Allyson Cole-Strauss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allyson Cole-Strauss. Allyson Cole-Strauss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fleming, Sheila M., S. Mark Scott, John G. Holden, et al.. (2025). Intrastriatal injection of alpha-synuclein preformed fibrils to rats results in L-DOPA reversible sensorimotor impairments and alterations in non-motor function. Frontiers in Neuroscience. 19. 1556447–1556447. 1 indexed citations

Patterson, Joseph R., Joseph Kochmanski, Christopher J. Kemp, et al.. (2024). Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils. npj Parkinson s Disease. 10(1). 7–7. 6 indexed citations

Patterson, Joseph R., Warren D. Hirst, Jacob W. Howe, et al.. (2022). Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein. npj Parkinson s Disease. 8(1). 61–61. 8 indexed citations

Sortwell, Caryl E., Mallory L. Hacker, D. Luke Fischer, et al.. (2021). BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease. Neuromodulation Technology at the Neural Interface. 25(6). 846–853. 8 indexed citations

Kochmanski, Joseph, Allyson Cole-Strauss, Christopher J. Kemp, et al.. (2020). Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits. Neurobiology of Disease. 141. 104947–104947. 25 indexed citations

Fischer, D. Luke, Peggy Auinger, John L. Goudreau, et al.. (2020). BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease. Neurotherapeutics. 17(4). 1785–1795. 15 indexed citations

Chen, Xi, Erin T. Williams, Nathan Levine, et al.. (2019). Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration. Proceedings of the National Academy of Sciences. 116(12). 5765–5774. 75 indexed citations

Fischer, D. Luke, Peggy Auinger, John L. Goudreau, et al.. (2018). Bdnf variant is associated with milder motor symptom severity in early-stage Parkinson's disease. Parkinsonism & Related Disorders. 53. 70–75. 15 indexed citations

Fischer, D. Luke, Christopher J. Kemp, Allyson Cole-Strauss, et al.. (2017). Subthalamic Nucleus Deep Brain Stimulation Employs trkB Signaling for Neuroprotection and Functional Restoration. Journal of Neuroscience. 37(28). 6786–6796. 42 indexed citations

10.

Fischer, D. Luke, Timothy J. Collier, Allyson Cole-Strauss, et al.. (2015). High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine. PLoS ONE. 10(7). e0133957–e0133957. 15 indexed citations

11.

Madhavan, Lalitha, Brian F. Daley, Beverly L. Davidson, et al.. (2015). Sonic Hedgehog Controls the Phenotypic Fate and Therapeutic Efficacy of Grafted Neural Precursor Cells in a Model of Nigrostriatal Neurodegeneration. PLoS ONE. 10(9). e0137136–e0137136. 12 indexed citations

12.

Polinski, Nicole K., Sara E. Gombash, Fredric P. Manfredsson, et al.. (2014). Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain. Neurobiology of Aging. 36(2). 1110–1120. 14 indexed citations

13.

Spieles-Engemann, Anne L., Kathy Steece‐Collier, Michael M. Behbehani, et al.. (2011). Subthalamic Nucleus Stimulation Increases Brain Derived Neurotrophic Factor in the Nigrostriatal System and Primary Motor Cortex. Journal of Parkinson s Disease. 1(1). 123–136. 76 indexed citations

14.

McNamara, Robert K., Ronald J. Jandacek, Therese Rider, et al.. (2011). Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: Relationship with liver delta6-desaturase expression. Schizophrenia Research. 129(1). 57–65. 33 indexed citations

15.

Gombash, Sara E., Jack W. Lipton, Timothy J. Collier, et al.. (2011). Striatal Pleiotrophin Overexpression Provides Functional and Morphological Neuroprotection in the 6-Hydroxydopamine Model. Molecular Therapy. 20(3). 544–554. 27 indexed citations

16.

McNamara, Robert K., Ronald J. Jandacek, Therese Rider, et al.. (2010). Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: Relationship with central serotonin turnover. Prostaglandins Leukotrienes and Essential Fatty Acids. 83(4-6). 185–191. 90 indexed citations

17.

Cole-Strauss, Allyson. (1999). Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract. Nucleic Acids Research. 27(5). 1323–1330. 106 indexed citations

18.

Cole-Strauss, Allyson, et al.. (1998). Targeted gene correction: a new strategy for molecular medicine. Molecular Medicine Today. 4(10). 431–437. 42 indexed citations

19.

Cole-Strauss, Allyson, et al.. (1997). Targeted gene conversion in a mammalian CD34 + -enriched cell population using a chimeric RNA/DNA oligonucleotide. Journal of Molecular Medicine. 75(11-12). 829–835. 41 indexed citations

20.

Cole-Strauss, Allyson, et al.. (1997). Recombinational Repair of Genetic Mutations. Antisense and Nucleic Acid Drug Development. 7(3). 211–216. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact